WASHINGTON (MedPage Today) -- An FDA advisory panel met recently to help decide the classification fate of several cardiovascular devices -- and one of them did not fare as well as the device maker had hoped. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment